The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant(Supplement) Understand Me for Life: Using Noise-augmented Automatic Speech Recognition to Improve Intelligibility in Parkinson’s Disease
Study Rationale: Most people with Parkinson’s disease (PD) develop voice and speech problems at some point during the course of the disease. Such problems, collectively known as the motor speech...
-
Research Grant, 2023Leveraging Gene Expression Data to Redefine Parkinson’s Disease and the Pathways Driving Disease in Different Individuals
Study Rationale: People with Parkinson’s disease (PD) share some common problems, such as stiffness, slowness of movement and tremors. However, these symptoms vary in severity, and individuals often...
-
Parkinson’s Pathway Molecular Data Analysis Program, 2023Characterization of Parkinson’s Disease Clinical Subtypes Using Multiple Immunologic and Genetic Markers
Study Rationale: Parkinson’s disease (PD) is an umbrella term that encompasses a highly heterogeneous domain of clinical manifestations, which makes the development of effective therapeutic strategies...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Interrogating LRRK2 Variants Common in Asian Populations to Discover Unique Biomarkers for Parkinson’s Disease
Study Rationale: Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease (PD). Many studies have focused on the LRRK2 G2019S mutation found in Caucasians, and less is...
-
Circuits & Cellular Targets for PD’s Symptoms, 2023Unbiased Identification of New Targets for Deep Brain Stimulation to Treat Gait and Balance Impairments in Parkinson’s Disease
Study Rationale: Over time, people with Parkinson’s disease (PD) develop problems with their ability to walk that can cause serious injuries and curtail their independence. Mice with a particular...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Targeting a Phospholipid Unique to Mitochondrial Membranes as a Therapeutic for Parkinson’s Disease
Study Rationale: Mitochondria are energy-generating structures vital to the health of all cells. In Parkinson’s disease (PD), mitochondrial dysfunction leads to neuronal degeneration and to the motor...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.